Ellenbogen Michael 4

What Happened
Michael Ellenbogen, a director of Evolv Technologies Holdings, exercised 80,745 stock options (vesting per footnote) and immediately sold the 80,745 shares on July 15, 2026. The options were exercised at $0.24 per share (cost $19,379). The shares were sold in multiple transactions at a weighted average price of $5.94 per share, generating gross proceeds of approximately $479,625. A derivative line showing a $0.00 disposition reflects the option conversion/settlement on exercise.

Key Details

• Transaction date: July 15, 2026; Form filed July 17, 2026 (appears timely).
• Exercise: 80,745 shares exercised at $0.24 (total cost $19,379). (Code M)
• Sale: 80,745 shares sold at a weighted average price of $5.94 (total proceeds ~$479,625). (Code S)
• Plan/authorization: Sales were effected under a Rule 10b5-1 trading plan entered June 12, 2025 (Footnote F1).
• Price detail: reported sale price is a weighted average; multiple trades were executed (Footnote F2).
• Vesting: option vested 25% on Jan 31, 2018 and monthly thereafter (Footnote F3).
• Shares owned after the transaction: not specified in this Form 4.

Context
This was an exercise-plus-sale (effectively a cashless sell) where the insider exercised vested options and sold the resulting shares the same day. Sales under a pre-established 10b5-1 plan are generally scheduled in advance and do not necessarily indicate a change in the insider’s view of the company. All figures above are gross proceeds (before commissions, taxes, or other fees).